Clinical Trial Update: Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on Yong Chong Cao Capsule for mild to severe chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Yong Chong Cao Capsule (Yong Chong Cao Capsule)

Snippet

Sponsor: Henan University of Traditional Chinese Medicine | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: UNKNOWN